Latest AI and machine learning research in fda general for healthcare professionals.
Background Although CT-based body composition (BC) metrics may inform disease risk and outcomes, obtaining these metrics has been too resource intensive for large-scale use. Thus, population-wide distributions of BC remain uncertain. Purpose To demonstrate the validity of fully automated, deep learning BC analysis from abdominal CT examinations, to define demographically adjusted BC reference curv...
Previously, our group predicted commercially available Food and Drug Administration (FDA) approved drugs that can inhibit each step of the replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using a deep learning-based drug-target interaction model called Molecule Transformer-Drug Target Interaction (MT-DTI). Unfortunately, additional clinically significant treatment option...
Predicting whether a chemical structure leads to a desired or adverse biological effect can have a significant impact for in silico drug discovery. In...
Screening agrochemicals and pharmaceuticals for potential liver toxicity is required for regulatory approval and is an expensive and time-consuming pr...
Classical drug design methodologies are hugely costly and time-consuming, with approximately 85% of the new proposed molecules failing in the first th...
When performing structural inspection, the generation of three-dimensional (3D) point clouds is a common resource. Those are usually generated from ph...
The current COVID-19 pandemic caused by a novel coronavirus SARS-CoV-2 urgently calls for a working therapeutic. Here, we report a computation-based w...
BACKGROUND: Cytokines are a class of small proteins that act as chemical messengers and play a significant role in essential cellular processes includ...
COVID-19 is an emerging disease with transmissibility and severity. So far, there are no effective therapeutic drugs or vaccines for COVID-19. The mos...
OBJECTIVES: To determine the extent and disclosure of financial ties to industry and use of scientific evidence in comments on a US Food and Drug Admi...
Successful deployment of machine learning algorithms in healthcare requires careful assessments of their performance and safety. To date, the FDA appr...
I applaud the authors of Feng (2020) for tackling a challenging statistical problem on approval policies for software as a medical device (SaMD). The...
We thank the discussants for sharing their unique perspectives on the problem of designing automatic algorithm change protocols (aACPs) for machine le...
Machine learning models for radiology benefit from large-scale data sets with high quality labels for abnormalities. We curated and analyzed a chest c...
The gut-brain axis (GBA) is a biochemical link that connects the central nervous system (CNS) and enteric nervous system (ENS). Clinical and experimen...
Real-world evidence (RWE), conclusions derived from analysis of patients not treated in clinical trials, is increasingly recognized as an opportunity ...
While both non-destructive evaluation (NDE) and structural health monitoring (SHM) share the objective of damage detection and identification in struc...
OBJECTIVE: The use of poorly designed and improperly implemented health information technology (HIT) may compound risks because it can disrupt establi...
Inspired by the information transmission mechanism in the central nervous systems of life, synapse-mimicking devices have been designed and fabricated...